VIPALANEBART
UNII 6QJ88LL4BG

Substance Identification & Data

This profile provides standardized clinical and technical data for Vipalanebart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6QJ88LL4BG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2642173-04-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6QJ88LL4BG

CAS Registry Number

2642173-04-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VIPALANEBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190752

National Cancer Institute reference terminology for clinical and research data.

INN ID

12534

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-12

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vipalanebart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VIPALANEBART

Common Names & Synonyms

IMMUNOGLOBULIN G4 (231-PROLINE,237-ALANINE,238-ALANINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE) (HUMAN MONOCLONAL LY3451838 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3451838 .KAPPA.-CHAIN, DIMER

VIPALANEBART [INN]

VIPALANEBART [USAN]